RxDoctor Payments Data

Rebekah Ayecock

Psychiatric/Mental Health · Dermott, ARNPI 1104251180

Payments from drug & device makers

$2,948in general payments, 2019–2025

Across 147 payments — averaging $20.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Teva Pharmaceuticals USA, Inc.$548
  • Otsuka America Pharmaceutical, Inc.$378
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$151
  • E.r. Squibb & Sons, L.L.C.$78
  • Vanda Pharmaceuticals Inc.$72
  • plus $273 from 13 others

What the payments were for

  • Food & beverage$2,72793%
  • Education$2217%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,948 in reported general payments places this provider in the 80th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate19$65,951
RexultiBrexpiprazole23$36,716
VraylarCariprazine Hcl18$28,269
TrintellixVortioxetine Hydrobromide20$11,350
Asenapine Maleate12$1,383
Lamotrigine68$934
Aripiprazole46$775
Olanzapine44$668
Zaleplon17$651
Trazodone Hcl83$630
Gabapentin46$589
Prazosin Hcl28$589
Mirtazapine31$546
Buspirone Hcl44$545
Quetiapine Fumarate44$503

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$17$65,95119 claims
Otsuka America Pharmaceutical, Inc.Rexulti$378$36,71623 claims
AbbVieVraylar$1,449$28,26918 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$38$11,35020 claims
Lilly USA, LLCOlanzapine$14$66844 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 359 psychiatric/mental health providers in Arkansas.

Other psychiatric/mental health in Dermott

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →